Multi-Analyte Respiratory Virus Antigen Detection Test
FDA product code SCA · 11 cleared devices
- Regulation
- 21 CFR 866.3987
- Review panel
- MI
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2025-01-13 – 2026-07-10
A multi-analyte respiratory virus antigen detection test is an in vitro diagnostic device intended for the detection and/or differentiation of respiratory viruses directly from respiratory clinical specimens. The device is intended to be performed at the site of sample collection, does not involve sample storage and/or transport.
iHealth Flu A&B/COVID-19 Rapid Test; iHealth Flu A&B/COVID-19 Rapid Test Pro
View details →iHealth Flu A&B/COVID-19/RSV Rapid Test; iHealth Flu A&B/COVID-19/RSV Rapid Test Pro
View details →Status™ COVID-19/Flu A&B
View details →Flowflex Plus RSV + Flu A/B + COVID Home Test
View details →CareSuperb COVID-19/Flu A&B Antigen Combo Home Test
View details →WELLlife Flu A&B Home Test; WELLlife Influenza A&B Test
View details →Nano-Check Influenza+COVID-19 Dual Test
View details →Flowflex Plus COVID-19 + Flu A/B Home Test
View details →WELLlife™ COVID-19 / Influenza A&B Home Test; WELLlife™ COVID-19 / Influenza A&B AntigenTest
View details →QuickFinder COVID-19/Flu Antigen Self Test / QuickFinder COVID-19/Flu Antigen Pro Test
View details →No matching devices.
Advertisement